Tirzepatide advantages in trials: Greater total weight loss, stronger HbA1c reduction, favorable body composition changes, long-term durability data Semaglutide advantages in trials: Established cardiovascular outcomes data (SELECT trial), longer real-world track record, oral formulation option Both medications: Require lifestyle changes to maximize results
Furthermore, they suggest initiating treatment for hyperuricemia when the serum uric acid level exceeds 8 mg/dl with at least one complication, or above 9 mg/dl without any complications
Wegovy is a clinically evaluated therapy that offers new hope for Canadians living with cardiovascular disease and obesity
In December 2021, a trial court ruled that the hostile/warlike exclusion covers acts of physical warfare only, not malware attacks
Compared to placebo and other treatments, it provides longer-lasting blood sugar control and more sustained weight loss
You can opt for different pharmaceuticals, stay within the semaglutide family, turn to natural supplements, or make lifestyle changes
![List of current GLP-1 and its analogs [36-39]](https://www.researchgate.net/publication/371322849/figure/tbl1/AS:11431281165596278@1686056417230/List-of-current-GLP-1-and-its-analogs-36-39.png)
00197-4/asset/bc822c6e-5915-4cb3-97bc-7187c857a496/main.assets/gr1_lrg.jpg)
